Susquehanna International Group’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.4K Sell
11,373
-18,368
-62% -$171K ﹤0.01% 12500
2025
Q4
$365K Buy
+29,741
New +$486K ﹤0.01% 9492
2025
Q3
Sell
-28,662
Closed -$455K 13483
2025
Q2
$387K Buy
28,662
+612
+2% +$6.7K ﹤0.01% 9774
2025
Q1
$243K Sell
28,050
-17,644
-39% -$108K ﹤0.01% 10531
2024
Q4
$222K Buy
+45,694
New +$255K ﹤0.01% 10485
2024
Q1
Sell
-21,611
Closed -$309K 13007
2023
Q4
$309K Sell
21,611
-85,163
-80% -$817K ﹤0.01% 9770
2023
Q3
$831K Sell
106,774
-62,428
-37% -$679K ﹤0.01% 7064
2023
Q2
$2.42M Sell
169,202
-32,714
-16% -$466K ﹤0.01% 4761
2023
Q1
$2.95M Buy
+201,916
New +$3.38M ﹤0.01% 4359
2022
Q2
Sell
-8,135
Closed -$241K 13639
2022
Q1
$307K Buy
+8,135
New +$360K ﹤0.01% 10227
2021
Q2
Sell
-39,591
Closed -$2.01M 13054
2021
Q1
$1.93M Sell
39,591
-9,067
-19% -$437K ﹤0.01% 6017
2020
Q4
$1.52M Buy
+48,658
New +$1.19M ﹤0.01% 5722
2020
Q2
Sell
-63,964
Closed -$580K 10685
2020
Q1
$580K Buy
+63,964
New +$607K ﹤0.01% 6594
2019
Q4
Sell
-19,591
Closed -$284K 10374
2019
Q3
$284K Buy
+19,591
New +$303K ﹤0.01% 8408
2019
Q2
Sell
-46,870
Closed -$633K 10655
2019
Q1
$596K Buy
46,870
+23,658
+102% +$308K ﹤0.01% 5947
2018
Q4
$255K Buy
+23,212
New +$343K ﹤0.01% 7305

Other funds holding OPRX

Susquehanna International Group's OPRX Position: Q1 2026 in Review

Susquehanna International Group reduced its OptimizeRx (OPRX) stake by 62% in Q1 2026, selling an estimated $171K and leaving 11,373 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12500.

Susquehanna International Group first reported a position in OPRX in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.95M in Q1 2023. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Susquehanna International Group held 11,373 shares of OptimizeRx worth $71.4K as of Q1 2026.
  • Susquehanna International Group sold 18,368 OptimizeRx shares in Q1 2026, an estimated $171K.
  • OptimizeRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12500 holding.
  • Susquehanna International Group first reported a position in OptimizeRx in Q4 2018 and has held it in 16 quarters since.
  • Susquehanna International Group's OptimizeRx position peaked at $2.95M in Q1 2023.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.